Literature DB >> 24910434

APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.

Stephen Henderson1, Ankur Chakravarthy2, Xiaoping Su3, Chris Boshoff2, Tim Robert Fenton4.   

Abstract

APOBEC3B cytosine deaminase activity has recently emerged as a significant mutagenic factor in human cancer. APOBEC activity is induced in virally infected cells, and APOBEC signature mutations occur at high frequency in cervical cancers (CESC), over 99% of which are caused by human papillomavirus (HPV). We tested whether APOBEC-mediated mutagenesis is particularly important in HPV-associated tumors by comparing the exomes of HPV+ and HPV- head and neck squamous cell carcinomas (HNSCCs) sequenced by The Cancer Genome Atlas project. As expected, HPV- HNSCC displays a smoking-associated mutational signature, whereas our data suggest that reduced exposure to exogenous carcinogens in HPV+ HNSCC creates a selective pressure that favors emergence of tumors with APOBEC-mediated driver mutations. Finally, we provide evidence that APOBEC activity is responsible for the generation of helical domain hot spot mutations in the PIK3CA gene across multiple cancers. Our findings implicate APOBEC activity as a key driver of PIK3CA mutagenesis and HPV-induced transformation.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24910434     DOI: 10.1016/j.celrep.2014.05.012

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  163 in total

1.  The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.

Authors:  Brandon Leonard; Jennifer L McCann; Gabriel J Starrett; Leah Kosyakovsky; Elizabeth M Luengas; Amy M Molan; Michael B Burns; Rebecca M McDougle; Peter J Parker; William L Brown; Reuben S Harris
Journal:  Cancer Res       Date:  2015-09-29       Impact factor: 12.701

Review 2.  Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.

Authors:  Farhoud Faraji; Munfarid Zaidi; Carole Fakhry; Daria A Gaykalova
Journal:  Microbes Infect       Date:  2017-06-12       Impact factor: 2.700

3.  APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.

Authors:  Daniel L Faden; Fei Ding; Yan Lin; Shuyan Zhai; Fengshen Kuo; Timothy A Chan; Luc G Morris; Robert L Ferris
Journal:  Oral Oncol       Date:  2019-07-30       Impact factor: 5.337

4.  HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.

Authors:  Kayla L Conner; Asra N Shaik; Elmira Ekinci; Seongho Kim; Julie J Ruterbusch; Michele L Cote; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2020-01-16

Review 5.  CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck.

Authors:  Camelia Billard-Sandu; Yun-Gan Tao; Marie-Paule Sablin; Gabriela Dumitrescu; David Billard; Eric Deutsch
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-11       Impact factor: 2.503

6.  Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.

Authors:  C Cleary; J E Leeman; D S Higginson; N Katabi; E Sherman; L Morris; S McBride; N Lee; N Riaz
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-04-01       Impact factor: 4.126

Review 7.  Precision medicine for metastatic breast cancer--limitations and solutions.

Authors:  Monica Arnedos; Cecile Vicier; Sherene Loi; Celine Lefebvre; Stefan Michiels; Herve Bonnefoi; Fabrice Andre
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

Review 8.  Hypermutation in human cancer genomes: footprints and mechanisms.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

Review 9.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

10.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

Authors:  S Kondo; K Wakae; N Wakisaka; Y Nakanishi; K Ishikawa; T Komori; M Moriyama-Kita; K Endo; S Murono; Z Wang; K Kitamura; T Nishiyama; K Yamaguchi; S Shigenobu; M Muramatsu; T Yoshizaki
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.